Cargando…
Natural Products Targeting PI3K/AKT in Myocardial Ischemic Reperfusion Injury: A Scoping Review
This scoping review aimed to summarize the effects of natural products targeting phosphoinositide-3-kinases/serine/threonine kinase (PI3K/AKT) in myocardial ischemia-reperfusion injury (MIRI). The review details various types of natural compounds such as gypenoside (GP), gypenoside XVII (GP-17), gen...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221447/ https://www.ncbi.nlm.nih.gov/pubmed/37242521 http://dx.doi.org/10.3390/ph16050739 |
_version_ | 1785049458384306176 |
---|---|
author | Syed Abd Halim, Syarifah Aisyah Abd Rashid, Norhashima Woon, Choy Ker Abdul Jalil, Nahdia Afiifah |
author_facet | Syed Abd Halim, Syarifah Aisyah Abd Rashid, Norhashima Woon, Choy Ker Abdul Jalil, Nahdia Afiifah |
author_sort | Syed Abd Halim, Syarifah Aisyah |
collection | PubMed |
description | This scoping review aimed to summarize the effects of natural products targeting phosphoinositide-3-kinases/serine/threonine kinase (PI3K/AKT) in myocardial ischemia-reperfusion injury (MIRI). The review details various types of natural compounds such as gypenoside (GP), gypenoside XVII (GP-17), geniposide, berberine, dihydroquercetin (DHQ), and tilianin which identified to reduce MIRI in vitro and in vivo by regulating the PI3K/AKT signaling pathway. In this study, 14 research publications that met the inclusion criteria and exclusion criteria were shortlisted. Following the intervention, we discovered that natural products effectively improved cardiac functions through regulation of antioxidant status, down-regulation of Bax, and up-regulation of Bcl-2 and caspases cleavage. Furthermore, although comparing outcomes can be challenging due to the heterogeneity in the study model, the results we assembled here were consistent, giving us confidence in the intervention’s efficacy. We also discussed if MIRI is associated with multiple pathological condition such as oxidative stress, ERS, mitochondrial injury, inflammation, and apoptosis. This brief review provides evidence to support the huge potential of natural products used in the treatment of MIRI due to their various biological activities and drug-like properties. |
format | Online Article Text |
id | pubmed-10221447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102214472023-05-28 Natural Products Targeting PI3K/AKT in Myocardial Ischemic Reperfusion Injury: A Scoping Review Syed Abd Halim, Syarifah Aisyah Abd Rashid, Norhashima Woon, Choy Ker Abdul Jalil, Nahdia Afiifah Pharmaceuticals (Basel) Review This scoping review aimed to summarize the effects of natural products targeting phosphoinositide-3-kinases/serine/threonine kinase (PI3K/AKT) in myocardial ischemia-reperfusion injury (MIRI). The review details various types of natural compounds such as gypenoside (GP), gypenoside XVII (GP-17), geniposide, berberine, dihydroquercetin (DHQ), and tilianin which identified to reduce MIRI in vitro and in vivo by regulating the PI3K/AKT signaling pathway. In this study, 14 research publications that met the inclusion criteria and exclusion criteria were shortlisted. Following the intervention, we discovered that natural products effectively improved cardiac functions through regulation of antioxidant status, down-regulation of Bax, and up-regulation of Bcl-2 and caspases cleavage. Furthermore, although comparing outcomes can be challenging due to the heterogeneity in the study model, the results we assembled here were consistent, giving us confidence in the intervention’s efficacy. We also discussed if MIRI is associated with multiple pathological condition such as oxidative stress, ERS, mitochondrial injury, inflammation, and apoptosis. This brief review provides evidence to support the huge potential of natural products used in the treatment of MIRI due to their various biological activities and drug-like properties. MDPI 2023-05-12 /pmc/articles/PMC10221447/ /pubmed/37242521 http://dx.doi.org/10.3390/ph16050739 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Syed Abd Halim, Syarifah Aisyah Abd Rashid, Norhashima Woon, Choy Ker Abdul Jalil, Nahdia Afiifah Natural Products Targeting PI3K/AKT in Myocardial Ischemic Reperfusion Injury: A Scoping Review |
title | Natural Products Targeting PI3K/AKT in Myocardial Ischemic Reperfusion Injury: A Scoping Review |
title_full | Natural Products Targeting PI3K/AKT in Myocardial Ischemic Reperfusion Injury: A Scoping Review |
title_fullStr | Natural Products Targeting PI3K/AKT in Myocardial Ischemic Reperfusion Injury: A Scoping Review |
title_full_unstemmed | Natural Products Targeting PI3K/AKT in Myocardial Ischemic Reperfusion Injury: A Scoping Review |
title_short | Natural Products Targeting PI3K/AKT in Myocardial Ischemic Reperfusion Injury: A Scoping Review |
title_sort | natural products targeting pi3k/akt in myocardial ischemic reperfusion injury: a scoping review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221447/ https://www.ncbi.nlm.nih.gov/pubmed/37242521 http://dx.doi.org/10.3390/ph16050739 |
work_keys_str_mv | AT syedabdhalimsyarifahaisyah naturalproductstargetingpi3kaktinmyocardialischemicreperfusioninjuryascopingreview AT abdrashidnorhashima naturalproductstargetingpi3kaktinmyocardialischemicreperfusioninjuryascopingreview AT woonchoyker naturalproductstargetingpi3kaktinmyocardialischemicreperfusioninjuryascopingreview AT abduljalilnahdiaafiifah naturalproductstargetingpi3kaktinmyocardialischemicreperfusioninjuryascopingreview |